Patent Oppositions in peptide synthesis industry

Explore the competitive field of peptide synthesis where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in peptide synthesis technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the peptide synthesis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the peptide synthesis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 29, 2026STORZ
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026DEVA HOLDING
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 27, 2026GREINER
Methods For Treating Cancer With Anti-Pd-1 AntibodiesMERCK SHARP & DOHMEJul 22, 2026ABBOTT PRODUCTION OPERATIONS
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 17, 2026POHLMAN
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 13, 2026MANZER
Methods Of Reducing Particle Formation And Compositions Formed TherebyREGENERON PHARMACEUTICALSJul 8, 2026HAMPTON KNOWLES
Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19FMERCK SHARP & DOHMEJun 24, 2026SK BIOSCIENCE
Improved Protein RecoveryBRISTOL MYERS SQUIBBJun 24, 2026OETKE
Pharmaceutical Compositions Comprising CabotegravirVIIV HEALTHCAREJun 19, 2026ELKINGTON AND FIFE

To stay ahead in the competitive peptide synthesis industry, companies are constantly innovating. Here are the top patents facing oppositions in the peptide synthesis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 6, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH16
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHE15
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS15
Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH14
Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH12
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE12
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI11
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN11
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10